Victory Capital Management Inc. decreased its position in DA32 Life Science Tech Acquisition Corp. (NASDAQ:DALS – Get Rating) by 1.7% during the 1st quarter, according to the company in its most recent filing with the SEC. The fund owned 235,925 shares of the company's stock after selling 3,960 shares during the quarter. Victory Capital Management Inc. owned 0.92% of DA32 Life Science Tech Acquisition worth $2,300,000 at the end of the most recent reporting period.

Separately, Exos Asset Management LLC lifted its position in DA32 Life Science Tech Acquisition by 4.6% during the 1st quarter. Exos Asset Management LLC now owns 76,951 shares of the company's stock worth $748,000 after buying an additional 3,402 shares in the last quarter. Hedge funds and other institutional investors own 60.86% of the company's stock.

DA32 Life Science Tech Acquisition Stock Performance

Shares of NASDAQ DALS opened at $9.72 on Friday. The firm's 50-day simple moving average is $9.70 and its 200 day simple moving average is $9.69. DA32 Life Science Tech Acquisition Corp. has a 12-month low of $9.58 and a 12-month high of $10.26.

DA32 Life Science Tech Acquisition Company Profile

DA32 Life Science Tech Acquisition Corp. does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. The company intends to identify business combination targets in the biotechnology and life science infrastructure sectors.

Read More

• Get a free copy of the StockNews.com research report on DA32 Life Science Tech Acquisition (DALS)
• Look at Honeywell for a Steady and Diversified Stock
• Why Invest in High-Yield Dividend Stocks?
• Disney (NYSE: DIS) Shares Just Gave Investors A Massive Signal
• Find and Profitably Trade Stocks at 52-Week Lows
• Solar Stocks Shine Brightly After Passage Of Clean Energy Bill

Want to see what other hedge funds are holding DALS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DA32 Life Science Tech Acquisition Corp. (NASDAQ:DALS – Get Rating).

Receive News & Ratings for DA32 Life Science Tech Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DA32 Life Science Tech Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.